UK MHRA GMP and GDP Inspection Success
Diamond Compliance and Quality Limited (DCQ) are pleased to announce the positive outcome of an on-site GMP and GDP regulatory inspection, by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), of a UK based client. A DCQ representative worked with the client to write a new pharmaceutical quality system and was in attendance during the MHRA audit in March 2020.
The MHRA inspection resulted in no Critical observations, one Major observation being raised along with 5 findings classified as Others.
This has resulted in the client being granted their first licences, an MS and WDA(H), to allow them to import a specials product and carry out wholesale activities. DCQ will continue to work with the client in an RP and QC capacity.